Jeffery Taubenberger, the acting head of the NIAID, the NIH’s infectious disease institute, is reported to have stepped down.
Vetenskapsnyheter
The DOJ alleges Elevance fraudulently billed the government for inaccurate medical diagnoses.
Watch as NIH Director Jay Bhattacharya is questioned by the Senate Appropriations Committee this morning on President Trump’s budget proposal for the 2027 fiscal year.
Eli Lilly reported that in a late-stage trial, its next-generation obesity drug led to weight loss approaching the effectiveness seen with bariatric surgery
A surgeon general's report on screen time, the health impact of bullet fragments, and more Morning Rounds news
A next-gen Eli Lilly obesity drug led to bariatric-surgery levels of weight loss in a study, but also saw patients dropping out because of side effects.
STAT+: After warning letter, Whoop and FDA in discussions about controversial blood pressure feature
Whoop is yet to resolve a dispute with the FDA over a blood pressure feature, a top executive said at STAT's Breakthrough Summit.
It almost feels like the Trump administration is intentionally breaking the FDA, writes Lab Dish columnist Paul Knoepfler.
Living with bullet fragments in your body can lead to chronic pain, issues with mobility, depression, even lead poisoning.
In this edition of AI Prognosis, Brittany Trang explains in detail why 'AI co-scientist' tools may not be as helpful for scientists, yet.
Congressional Democrats are mounting a fresh effort to end a Medicare experiment to use AI to approve or deny care.
A UCSF team has submitted an application to the FDA seeking approval for a small trial of in utero gene therapy for a rare lysosomal storage disorder.
A public health advisory calls on parents, schools, and government to limit children's use of screens, saying some patterns of use “can pose real harm to children.”
Stricter limits on extra Medicaid funds are coming, stemming from President Trump's tax cut bill.
Growing evidence suggests it takes a sustained viral infection in the right genetic environment to lead to type 1 diabetes.
“As another Ebola outbreak unfolds, we cannot repeat the mistakes of the past,” writes Krutika Kuppalli.
STAT+: Biotech execs, academic expert lament impact of FDA turnover on rare disease drug development
How the ouster of key officials at the FDA has created anxiety and uncertainty for the developers of rare disease drugs.
Kennedy will have broad latitude to remake the panel, which helps determine what preventive care must be covered by health insurance.
The FDA's new path, the status of animal testing, and other biotech news from The Readout
Stephanie Haridopolos, a family medicine physician and senior HHS adviser, will take on the surgeon general's duties on an interim basis.
For Wall Street, the political risk of investing in drug companies has been demoted in comparison to other concerns
USAID cuts have painful outcomes for the Ebola outbreak, states sue over a new professional ed loan rule, and other health news
The WHO defended its Ebola response, noting it's national authorities who detect outbreaks. Marco Rubio had said the WHO was 'a little late'
It's part of Democrats' strategy to focus on health care affordability and access in drawing contrasts with Republicans ahead of the midterms.
An NIH leadership vacuum has persisted for months, with 15 of the 27 institutes being led by acting directors.